REFERENCES
1.Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol. 1986. 43:1150–1152.
2.Kim JK. Anti-GQ1b antibody syndrome; is the another name of Miller Fisher syndrome or advent of a new syndrome? J Korean Neurol Assoc. 2009. 27:307–312.
3.Nagashima T., Koga M., Odaka M., Hirata K., Yuki N. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Arch Neurol. 2007. 64:1519–1523.
4.Yang TI., Park YE., Kim JK., Cha SY., Kim TH, et al. Guillain-Barré syndrome with antibody to ganglioside GT1a. J Korean Neurol Assoc. 2010. 28:291–294.
5.Mori M., Kuwabara S., Fukutake T., Yuki N., Hattori T. Clinical features and prognosis of Miller-Fisher syndrome. Neurol. 2001. 56:1104–1106.
6.Kim S., Lee JH., Jo JW., Park KP., Kim DS. Unilateral facial palsy in acute ophthalmoplegia associated with Anti-GQ1b antibody. Korean J Clin Neurophysiol. 2011. 13:111–113.
7.Van Koningsveld R., Schmitz PIM., van der Meche FGA., Visser LH., Meulstee J., van Doorn PA, et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial. Lancet. 2004. 363:192–196.